-
-
公开(公告)号:KR102095889B1
公开(公告)日:2020-04-01
申请号:KR1020180116012
申请日:2018-09-28
Applicant: 국민대학교산학협력단
IPC: C12N1/14 , A23L31/00 , A23L33/105 , A61K36/484 , A61P5/24
-
公开(公告)号:KR101798882B1
公开(公告)日:2017-12-13
申请号:KR1020160084140
申请日:2016-07-04
Applicant: 에스케이바이오랜드 주식회사 , 국민대학교산학협력단
IPC: A61K36/73 , A61K31/192 , A61K31/366 , A23L1/30
Abstract: 본발명은여성갱년기질환의예방또는치료용조성물, 또는여성갱년기질환개선용건강기능식품조성물, 또는홍국균발효산물의제조방법에관한것이다. 본발명에따르면, 상기제조방법으로홍국균발효산물을제조할경우, 발효산물인 monacolin K를생산하도록함으로써, 이를여성갱년기질환의예방, 개선또는치료용조성물로서포함할경우, 여성갱년기질환의예방, 개선또는치료효과가우수하다.
-
公开(公告)号:KR101054808B1
公开(公告)日:2011-08-05
申请号:KR1020100111803
申请日:2010-11-10
Applicant: 주식회사 바이오리더스 , 국민대학교산학협력단 , 한국생명공학연구원 , 인제대학교 산학협력단
IPC: A61K31/765 , A61K31/74 , A61K31/195 , A61P3/00
CPC classification number: A61K31/785 , A23L33/175 , A61K31/195 , A61K31/765
Abstract: PURPOSE: A composition containing polygamma glutamic acid is provided to improve blood cholesterol level and to ensure anticoagulation effect without side effects and toxicity. CONSTITUTION: A pharmaceutical composition for treating diseases caused by cholesterol high content contains polygamma glutamic acid or salt thereof as an active ingredient. The diseases are obesity, hyperlipidemia, thrombosis, arteriosclerosis, or myocardial infarction. The salt is sodium salt, potassium salt, calcium salt, ammonium salt, or zinc salt. The polygamma galumatic acid is prepared by Bacillus subtilis strain.
Abstract translation: 目的:提供含有多糖谷氨酸的组合物,以提高血液中胆固醇水平,并确保抗凝作用,无副作用和毒性。 构成:用于治疗由胆固醇高含量引起的疾病的药物组合物含有作为活性成分的多糖谷氨酸或其盐。 这些疾病是肥胖症,高脂血症,血栓形成,动脉硬化或心肌梗死。 盐是钠盐,钾盐,钙盐,铵盐或锌盐。 多糖半乳糖酸是通过枯草芽孢杆菌菌株制备的。
-
-
-